Blocking natural killer cell activity.
D006680:HLA Antigens / Q000276:immunology* / Q000494:pharmacology*; D015395:Histocompatibility Antigens Class I / Q000276:immunology* / Q000494:pharmacology*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007694:Killer Cells, Natural / Q000276:immunology* / Q000502:physiology; D012107:Research Design; D012680:Sensitivity and Specificity; D014180:Transplantation / Q000379:methods; D006113:United Kingdom; D000097625:HLA-E Antigens
D006680:HLA Antigens; D015395:Histocompatibility Antigens Class I; D000097625:HLA-E Antigens